Clinical trial

Study of the Treatment of Articular Repair (STAR)

NCT00158613 · Vericel Corporation, Industry · Completed

Key facts

NCT number NCT00158613
Title Study of the Treatment of Articular Repair (STAR)
Official title A Prospective, Longitudinal Within-Patient Evaluation of the Effectiveness (Durability) of Carticel® (Autologous Cultured Chondrocytes) Compared to Non-Carticel Surgical Treatment for Articular Cartilage Defects of the Knee.
Lead sponsor Vericel Corporation, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Articular Cartilage
Intervention type Biological
Interventions Carticel (autologous cultured chondrocyte) implantation
Enrollment 126
Start date Mar 1, 2000
Primary completion Nov 1, 2005
Completion Nov 1, 2005
First posted Sep 12, 2005
Last update posted May 11, 2021
Countries Canada, United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies